Compounds > metformin

metformin and sulfenamide

metformin has been researched along with sulfenamide in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (16.67)	29.6817
2010's	5 (83.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huttunen, KM; Järvinen, T; Kemppainen, E; Laine, K; Leppänen, J; Mannila, A; Rautio, J; Vepsäläinen, J	1
Huttunen, KM; Laine, K; Leppänen, J; Rautio, J; Vepsäläinen, J	1
Huttunen, KM; Peura, L	1
Huttunen, KM; Markowicz-Piasecka, M; Mikiciuk-Olasik, E; Sikora, J	1
Huttunen, KM; Markowicz-Piasecka, M; Mateusiak, Ł; Mikiciuk-Olasik, E; Sikora, J	1
Broncel, M; Huttunen, KM; Markowicz-Piasecka, M; Sikora, J	1

Other Studies

6 other study(ies) available for metformin and sulfenamide

Article	Year
The first bioreversible prodrug of metformin with improved lipophilicity and enhanced intestinal absorption. Journal of medicinal chemistry, 2009, Jul-23, Volume: 52, Issue:14 Topics: Animals; Biological Availability; Buffers; Drug Design; Humans; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Male; Metformin; Octanols; Prodrugs; Rats; Rats, Wistar; Solutions; Sulfamerazine; Water	2009
Convenient microwave-assisted synthesis of lipophilic sulfenamide prodrugs of metformin. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2013, Jul-16, Volume: 49, Issue:4 Topics: Animals; Caco-2 Cells; Chemistry, Pharmaceutical; Cysteine; Glutathione; Humans; Hypoglycemic Agents; Metformin; Microwaves; Permeability; Prodrugs; Rats; Sulfamerazine	2013
Sustained release of metformin via red blood cell accumulated sulfenamide prodrug. Journal of pharmaceutical sciences, 2014, Volume: 103, Issue:7 Topics: Administration, Oral; Animals; Delayed-Action Preparations; Dose-Response Relationship, Drug; Erythrocytes; Half-Life; Hypoglycemic Agents; Injections, Intravenous; Metformin; Prodrugs; Rats; Sulfamerazine; Time Factors	2014
Biocompatible sulfenamide and sulfonamide derivatives of metformin can exert beneficial effects on plasma haemostasis. Chemico-biological interactions, 2018, Jan-25, Volume: 280 Topics: Biocompatible Materials; Drug Stability; Erythrocytes; Fibrinolysis; Hemolysis; Metformin; Microscopy, Phase-Contrast; Partial Thromboplastin Time; Prothrombin Time; Sulfamerazine; Sulfanilamide; Sulfanilamides	2018
Sulfenamide and sulfonamide derivatives of metformin can exert anticoagulant and profibrinolytic properties. Chemico-biological interactions, 2018, Mar-25, Volume: 284 Topics: Anticoagulants; Antithrombin III; Blood Coagulation; Diabetes Mellitus, Type 2; Factor X; Fibrinolysis; Humans; Metformin; Protein C; Sulfamerazine; Sulfonamides; Thrombin Time	2018
Sulfenamide and Sulfonamide Derivatives of Metformin - A New Option to Improve Endothelial Function and Plasma Haemostasis. Scientific reports, 2019, 04-25, Volume: 9, Issue:1 Topics: Diabetes Mellitus, Type 2; Human Umbilical Vein Endothelial Cells; Humans; Metformin; Myocytes, Smooth Muscle; Sulfamerazine; Sulfonamides; Thromboplastin; von Willebrand Factor	2019